Consumer Discretionary • Catalog/Specialty Distribution
$1.55 ▼ -0.03
(-1.90%)
MKT CAP: $170.4M • VOL: 4.38M
52W L $1 52W H $8
NXH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.04B | $1.39B | $1.56B |
| YoY Revenue Growth % | -25.1% | -10.6% | — |
| Gross Profit | $257.5M | $290.2M | — |
| Gross Margin % | 24.7% | 20.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$61.2M | -$184.1M | -$144.0M |
| Operating Margin % | -5.9% | -13.2% | -9.2% |
| Net Income (GAAP) | $0 | -$258.8M | -$307.8M |
| EBITDA (Normalized) | -$55.3M | -$172.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$56.7M | -$174.3M | -$18.6M |
| Capital Expenditures (CapEx) | $7.4M | $14.3M | — |
| Free Cash Flow (FCF) | -$64.1M | -$188.6M | -$18.6M |
| FCF Margin % | -6.1% | -13.5% | -1.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $175.3M | $159.2M | — |
| Total Debt (Short + Long Term) | $0 | — | — |
| Total Stockholders' Equity | $217.6M | $162.7M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NXH.